Estíbaliz Castillero

2.0k total citations
47 papers, 1.5k citations indexed

About

Estíbaliz Castillero is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Estíbaliz Castillero has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 17 papers in Physiology. Recurrent topics in Estíbaliz Castillero's work include Muscle Physiology and Disorders (15 papers), Adipose Tissue and Metabolism (12 papers) and Exercise and Physiological Responses (7 papers). Estíbaliz Castillero is often cited by papers focused on Muscle Physiology and Disorders (15 papers), Adipose Tissue and Metabolism (12 papers) and Exercise and Physiological Responses (7 papers). Estíbaliz Castillero collaborates with scholars based in United States, Spain and Germany. Estíbaliz Castillero's co-authors include Nima Alamdari, Isaac George, P. Christian Schulze, Ana Isabel Martı́n, Asunción López‐Calderón, Zaira Aversa, María López-Menduiña, Per-Olof J. Hasselgren, Ruiping Ji and Peter J. Kennel and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Estíbaliz Castillero

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Estíbaliz Castillero United States 23 789 390 355 195 192 47 1.5k
Christoph Zechner United States 10 1.2k 1.5× 672 1.7× 438 1.2× 266 1.4× 438 2.3× 18 1.9k
Yuichi Akasaki Japan 16 683 0.9× 465 1.2× 243 0.7× 310 1.6× 193 1.0× 42 1.4k
Gérald Hugon France 21 1.2k 1.5× 476 1.2× 219 0.6× 101 0.5× 120 0.6× 53 1.7k
Daniela Fiore Italy 15 676 0.9× 365 0.9× 167 0.5× 141 0.7× 287 1.5× 25 1.4k
William G. Aschenbach United States 17 772 1.0× 397 1.0× 207 0.6× 80 0.4× 241 1.3× 23 1.6k
Sonomi Maruyama Japan 13 429 0.5× 638 1.6× 545 1.5× 536 2.7× 155 0.8× 22 1.4k
Renata O. Pereira United States 22 888 1.1× 516 1.3× 325 0.9× 230 1.2× 178 0.9× 42 1.5k
Genzo Iguchi Japan 28 501 0.6× 467 1.2× 221 0.6× 657 3.4× 337 1.8× 104 2.3k
Janne R. Hingst Denmark 15 949 1.2× 682 1.7× 116 0.3× 157 0.8× 176 0.9× 27 1.5k
Enrico Bertaggia Italy 10 676 0.9× 337 0.9× 104 0.3× 489 2.5× 108 0.6× 11 1.1k

Countries citing papers authored by Estíbaliz Castillero

Since Specialization
Citations

This map shows the geographic impact of Estíbaliz Castillero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estíbaliz Castillero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estíbaliz Castillero more than expected).

Fields of papers citing papers by Estíbaliz Castillero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estíbaliz Castillero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estíbaliz Castillero. The network helps show where Estíbaliz Castillero may publish in the future.

Co-authorship network of co-authors of Estíbaliz Castillero

This figure shows the co-authorship network connecting the top 25 collaborators of Estíbaliz Castillero. A scholar is included among the top collaborators of Estíbaliz Castillero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estíbaliz Castillero. Estíbaliz Castillero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castillero, Estíbaliz, Chiara Camillo, Alex d'Angelo, et al.. (2024). Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium. Cardiovascular Pathology. 74. 107689–107689.
2.
Castillero, Estíbaliz, Daniel P. Howsmon, Bruno V. Rego, et al.. (2021). Altered Responsiveness to TGFβ and BMP and Increased CD45+ Cell Presence in Mitral Valves Are Unique Features of Ischemic Mitral Regurgitation. Arteriosclerosis Thrombosis and Vascular Biology. 41(6). 2049–2062. 2 indexed citations
3.
Howsmon, Daniel P., Bruno V. Rego, Estíbaliz Castillero, et al.. (2020). Mitral valve leaflet response to ischaemic mitral regurgitation: from gene expression to tissue remodelling. Journal of The Royal Society Interface. 17(166). 20200098–20200098. 20 indexed citations
4.
d'Angelo, Alex, Estíbaliz Castillero, Robert J. Levy, & Giovanni Ferrari. (2020). Abstract 15006: Serotonin Transporter (SERT) Knockout Leads to Increased Myocardial and Mitral Valvular Fibrosis in a Murine Model. Circulation. 142(Suppl_3). 1 indexed citations
5.
Zhang, Xiaokan, Ruiping Ji, Xianghai Liao, et al.. (2018). MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation. Circulation. 137(19). 2052–2067. 147 indexed citations
6.
Kennel, Peter J., Raymond C. Givens, Danielle L. Brunjes, et al.. (2017). Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. The Journal of Heart and Lung Transplantation. 37(3). 409–417. 77 indexed citations
7.
Kennel, Peter J., Hirokazu Akashi, Ruiping Ji, et al.. (2015). Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 308(9). H1078–H1085. 23 indexed citations
8.
Ji, Ruiping, Jennifer Y. Chang, Xianghai Liao, et al.. (2015). Abstract 17320: Inhibition of Ceramide Synthesis Preserves Cardiac Function and Increases Survival in Doxorubicin-induced Cardiomyopathy. Circulation. 132(suppl_3). 2 indexed citations
9.
Kennel, Peter J., Raymond C. Givens, Danielle L. Brunjes, et al.. (2015). Serum-Derived Exosomal Proteome Analysis of Patients With Heart Failure and After Heart Transplantation. The Journal of Heart and Lung Transplantation. 34(4). S301–S301. 1 indexed citations
10.
Castillero, Estíbaliz, Hirokazu Akashi, Catherine Wang, et al.. (2014). Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. Biochemical and Biophysical Research Communications. 457(1). 106–111. 41 indexed citations
11.
Castillero, Estíbaliz, et al.. (2013). PPARβ/δ Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting. PLoS ONE. 8(3). e59726–e59726. 33 indexed citations
12.
Castillero, Estíbaliz, Ana Isabel Martı́n, María Paz Nieto‐Bona, et al.. (2012). Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting. Endocrine Connections. 1(1). 1–12. 6 indexed citations
13.
Alamdari, Nima, Zaira Aversa, Estíbaliz Castillero, & Per-Olof J. Hasselgren. (2012). Acetylation and deacetylation—novel factors in muscle wasting. Metabolism. 62(1). 1–11. 56 indexed citations
14.
Aversa, Zaira, Nima Alamdari, Estíbaliz Castillero, et al.. (2012). β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy. Biochemical and Biophysical Research Communications. 423(4). 739–743. 37 indexed citations
15.
Martı́n, Ana Isabel, María Paz Nieto‐Bona, Estíbaliz Castillero, et al.. (2012). Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.. PubMed. 63(6). 649–59. 13 indexed citations
16.
Castillero, Estíbaliz, María López-Menduiña, Ana Isabel Martı́n, María Ángeles Villanúa, & Asunción López‐Calderón. (2011). Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1. Journal of Endocrinology. 210(3). 361–368. 11 indexed citations
17.
Alamdari, Nima, et al.. (2011). Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism. Biochemical and Biophysical Research Communications. 417(1). 528–533. 82 indexed citations
18.
Granado, Miriam, Julie A. Chowen, Cristina García‐Cáceres, et al.. (2009). Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats. Molecular and Cellular Endocrinology. 309(1-2). 67–75. 22 indexed citations
19.
Martı́n, Ana Isabel, María López-Menduiña, Estíbaliz Castillero, et al.. (2008). Ptgs2 activation by endotoxin mediates the decrease in Igf1, but not in Igfbp3, gene expression in the liver. Journal of Endocrinology. 198(2). 385–394. 7 indexed citations
20.
Priego, Teresa, Miriam Granado, Estíbaliz Castillero, et al.. (2006). Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression. Journal of Endocrinology. 190(3). 847–856. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026